Dose counter mechanisms for medicament delivery devices

Information

  • Patent Grant
  • 8511302
  • Patent Number
    8,511,302
  • Date Filed
    Friday, April 22, 2005
    19 years ago
  • Date Issued
    Tuesday, August 20, 2013
    11 years ago
Abstract
A dose counter mechanism is suitable for use with a medicament delivery device. The dose counter mechanism comprises a rollable tape (20) provided with indicia (22), a tape housing (10) and a tape collector spool (40). The tape housing comprises a tape dispenser housing (14) within which, in use, a roll (24) of the tape is inserted and a tape collector spool housing (16) within which, in use, the tape collector spool is mounted. The tape dispenser housing and the tape collector spool housing are connected by a tape display area (15).
Description

This application is a national stage application under 35 U.S.C. §371 from PCT Application No. PCT/GB2005/001572, filed Apr. 22, 2005, which claims the priority benefit of Great Britain Application No. 0409197.1, filed Apr. 24, 2004.


This invention relates to dose counter mechanisms for medicament delivery devices, and in particular to dose counter mechanisms for use with dry powder inhalers.


Dry powder inhalers, such as the CLICKHALER® inhaler produced by Innovata Biomed in the UK and described in European Patent No. 0539469, preferably include a dose counter mechanism for providing an indication of the number of doses that have been administered to a patient and/or the number of doses that remain in the inhaler. Conventional dose counter mechanisms for use with dry powder inhalers comprise a ratchet mechanism with indicia being carried by the ratchet wheel.


Attempts to improve conventional dose counter mechanisms have been made. In particular, UK Patent Application No. 0115519.1 (Publication No. GB 2366208) describes an inhaler dose meter comprising a tape wound on a dispensing spool, the free end of the tape being fixed to a receiving spool. The receiving spool includes a number of teeth that are engaged by a pawl each time the mouthpiece cover is closed, such that the receiving spool is rotated by a predetermined degree following each closure of the mouthpiece cover. A transparent window in the inhaler housing enables a user to view indicia carried by the tape wound on the receiving spool. Each rotation of the receiving spool causes a greater length of the tape to become wound onto the spool, such that the indicia visible though the transparent window are advanced.


However, the dose counter described by GB 2366208 suffers from many disadvantages, including the dose counter having many moving parts and also the poor visibility of the indicia carried by the tape.


There has now been devised an improved dose counter mechanism which overcomes or substantially mitigates the above-mentioned and/or other disadvantages associated with the prior art.


According to a first aspect of the invention, there is provided a dose counter mechanism suitable for use with a medicament delivery device, the mechanism comprising a rollable tape provided with indicia, a tape dispenser housing, and a tape collector spool, the dispenser housing and the tape collector spool being connected by a tape display area.


The dose counter mechanism according to the invention is advantageous principally because the only necessarily moving parts of the dose counter mechanism are the tape collector spool and the rollable tape. The dose counter mechanism according to the invention is therefore simpler and less expensive to manufacture, and may be less prone to failure, than prior art mechanisms. In addition, the tape display area enables the indicia carried by the tape to be presented in a more visible manner than for prior art mechanisms.


The rollable tape may be formed of a plastics material. The indicia are preferably printed on a surface of the tape, and preferably take the form of a series of numbers that indicate either the number of doses administered or the number of doses remaining within the medicament delivery device.


The tape dispenser housing preferably comprises an enclosure within which a roll of the tape is housed, and an opening through which the tape exits the tape dispenser housing. Most preferably, the tape dispenser housing has an opening that is sufficiently large for the roll of tape to be introduced into the tape dispenser housing, but is configured so as to retain the roll of tape within the tape dispenser housing, during use. In preferred embodiments, the tape dispenser housing comprises an enclosing wall having a generally C-shaped cross-section, and end flanges that prevent any lateral movement of the roll of tape.


It is particularly preferred that the tape that is held in the tape dispenser housing is formed into a simple roll, without being wound on a bobbin or the like. This greatly simplifies the manufacturing process.


The tape display area preferably has a smooth and generally flat surface that the tape overlies in use, at least one of the indicia provided on the part of the tape overlying the tape display area preferably being visible to a user. The tape may be transparent such that the tape display area forms the visible background for the indicia. In this case, the tape display area is preferably coloured distinctly relative to the colour of the indicia.


The collector spool is preferably rotatably mounted within a collector spool housing. The dispenser housing, the collector spool housing, and the tape display area are preferably formed as a single component, preferably by injection moulding in a plastics material.


A retaining clip is preferably also provided to ensure that the tape is sufficiently taut for the indicia to be readily visible. The retaining clip may also act to ensure that the tape lies flat against the tape display area during use, and to assist in retaining the roll of tape within the tape dispenser housing.


The dose counter mechanism preferably includes an actuator that acts to rotate the collector spool appropriately during use. In particular, the actuator preferably rotates the collector spool by a pre-determined degree each time a dose of medicament is dispensed from the medicament delivery device. Most preferably, this rotation of the collector spool by a pre-determined degree each time a dose of medicament is dispensed from the medicament delivery device causes the indicia visible to the user to change, preferably to an adjacent indicia provided on the tape. The actuator is therefore preferably operably linked to the actuator of the medicament delivery device that enables or causes a dose of medicament to be dispensed. Most preferably, the actuator of the dose counter mechanism and the actuator of the medicament delivery have a common component.


Where the actuator of the medicament delivery device is displaced along a linear path and then returned to its inoperative position each time a dose of medicament is dispensed, the actuator of the dose counter mechanism is also preferably displaced along a linear path and then returned to its inoperative position each time a dose of medicament is dispensed. The actuator of the dose counter mechanism is therefore preferably adapted to rotate the collector spool by a pre-determined degree on being displaced along a linear path and then returned to its inoperative position.


In presently preferred embodiments, the collector spool comprises an end plate having a plurality of projections that are engageable by the actuator, during use, to cause rotation of the collector spool. Preferably, the projections are spaced equiangularly about a peripheral part of the end plate.


The actuator preferably comprises first and second actuator arms, the first actuator arm engaging the collector spool when the actuator is displaced from its inoperative position, and the second actuator arm engaging the collector spool on the return stroke of the actuator to its inoperative position. Most preferably, the first actuator arm is engaged with a projection when the actuator is in its inoperative position, or the first actuator arm engages a projection immediately upon displacement of the actuator from its inoperative position, which then causes the first actuator arm to exert a force on the projection with which it is engaged so as to rotate the collector spool. The second actuator arm engages a projection on the return stroke of the actuator. The first and second actuator arms thus engage projections on opposite sides of the axis of rotation of the collector spool. In this way, the collector spool is rotated by the movement of the actuator.


According to a further aspect of the invention, there is provided a medicament delivery device comprising a dose counter mechanism as described above.


The medicament delivery device is preferably an inhaler, and more preferably a dry powder inhaler, such as the CLICKHALER® inhaler produced by Innovata Biomed in the UK and described in European Patent No. 0539469 or the combination therapy dry powder inhaler described in the published International patent application WO 01/39823. By a dry powder inhaler is meant an inhaler of the type in which a unit dose of medicament powder, either packaged as such or metered from a bulk reservoir of medicament, is presented to an airway and is then entrained in an airflow passing through the airway. The airflow is most commonly generated by the patient's act of inhalation.


According to a more specific aspect of the invention, there is thus provided an inhaler comprising a dose counter mechanism as described above.


A variety of medicaments may be administered by using the inhaler of the invention. Such medicaments are generally suitable for the treatment of asthma, COPD and respiratory infections. Such medicaments include, but are not limited to β2-agonists, eg fenoterol, formoterol, pirbuterol, reproterol, rimiterol, salbutamol, salmeterol and terbutaline; non-selective beta-stimulants such as isoprenaline; xanthine bronchodilators, eg theophylline, aminophylline and choline theophyllinate; anticholinergics, eg ipratropium bromide, oxitropium and tiotropium; mast cell stabilisers, eg sodium cromoglycate and ketotifen; bronchial anti-inflammatory agents, eg nedocromil sodium; and steroids, eg beclomethasone, fluticasone, budesonide, flunisolide, triamcinolone, mometasone and ciclesonide; and/or salts or derivatives thereof.


Specific combinations of medicaments which may be mentioned include combinations of steroids and β2-agonists. Examples of such combinations are beclomethasone dipropionate and formoterol; beclomethasone dipropionate and salmeterol; fluticasone and formoterol; fluticasone and salmeterol; budesonide and formoterol; budesonide and salmeterol; flunisolide and formoterol; flunisolide and salmeterol; ciclesonide and salmeterol; ciclesonide and formoterol; mometasone and salmeterol; and mometasone and formoterol.


Further medicaments which may be mentioned include systemically active materials, such as proteinaceous compounds and/or macromolecules, for example hormones and mediators, such as insulin, human growth hormone, leuprolide and alpha interferon, growth factors, anticoagulants, immunomodulators, cytokines and nucleic acids.





The invention will now be described in greater detail, by way of illustration only, with reference to the accompanying drawings, in which



FIG. 1 is a perspective view of a tape housing, a tape, and a retaining clip, that each form part of a dose counter mechanism according to the invention;



FIG. 2 is a perspective view of the tape housing, tape, and retaining clip of the dose counter mechanism, as well as a collector spool that also forms part of the dose counter mechanism, in an assembled configuration;



FIG. 3 is a side view of an actuator that forms part of the dose counter mechanism;



FIG. 4 is a side view of part of the actuator in engagement with the collector spool, when the actuator is in its normal configuration; and



FIG. 5 is a view similar to that of FIG. 4, but when the actuator is in its depressed configuration.





A dose counter mechanism according to the invention is shown in the Figures. The dose counter mechanism is intended for use with a dry powder inhaler (not shown in the Figures), for example the CLICKHALER® inhaler produced by Innovata Biomed in the UK and described in European Patent No 0539469B. Another example of a dry powder inhaler in which the dose counter mechanism may be incorporated is that described in European Patent No 1233805B. Such an inhaler is used for the delivery of two different medicaments.


The dose counter mechanism comprises a tape housing 10, a tape 20, a retaining clip 30, a collector spool 40, and an actuator 50.


The tape housing 10 is injection moulded in plastics material as a single component, and is shown in FIG. 1. The tape housing 10 comprises a side wall 11 that is adapted to be attached to a relevant part of a dry powder inhaler. Extending from one side of the side wall 11 is a first member having a generally cylindrical upper member 12 (as viewed in FIG. 1), and a second member having a rear wall 13, a dispenser housing 14, a tape display plate 15, and a collector spool housing 16.


The rear wall 13 is orientated substantially along the longitudinal axis of the tape housing 10, and is situated slightly below and rearward (as viewed in FIG. 1) of the first member 12. The dispenser housing 14 extends from the lower end of the rear wall 13, and comprises a front enclosing wall of C-shaped cross-section and a C-shaped end flange. An opening is therefore defined at the rear of the dispenser housing 14. In an assembled configuration, the dispenser housing 14 holds a roll of tape 20, and the end flange prevents any lateral movement of the roll of tape 20, during use.


A tape display plate 15 extends from a lower part of the dispenser housing 14 to the collector spool housing 16 at the lower end of the tape housing 10 (as viewed in FIG. 1). The front surface of the tape display plate 15 is smooth and generally flat, and has a central part that is aligned flush with the front edge of the side wall 11 of the tape housing 10. The smooth and generally flat nature of the front surface of the tape display plate 15 enables the tape 20 to be presented to a user in an easily readable configuration.


The collector spool housing 16 is cylindrical in form with one end extending from the side wall 11 of the tape housing 10, and the other end being open. A slot 17 is provided in the wall of the collector spool housing 16 through which the tape 20 enters before being wound on the collector spool 40 (part of which is shown in FIG. 2). The surface defining the upper edge of the slot 17 is radiussed.


The tape 20 is shown in FIG. 1 in a configuration that the tape 20 adopts when assembled within the dose counter mechanism. The tape 20 is a transparent plastics film with a series of numbers 22, from the number one to a number that indicates the number of doses contained within a fully charged dry powder inhaler, printed on an outer surface of the tape 20. The tape 20 is in the form of a roll 24 with the numbers 22 increasing towards the outer end of the tape 20, as shown in FIG. 1. The numbers 22 are printed in a colour that is clearly visible against the background formed by the tape display plate 15. The tape is simply formed into the roll 24, which is then inserted into the dispenser housing 14, without the use of a bobbin or the like.


The retaining clip 30 is formed from a resilient metal, such as mild steel, and has the form shown in FIG. 1. In particular, the retaining clip 30 comprises a front retainer 31, a rear retainer 32, and a connecting portion 33. The front and rear retainers 31,32 each include a pair of parallel arms that are planar in form and adapted to overlie the outer surface of the tape 20 in the assembled dose counter mechanism. The lower ends (as viewed in FIG. 1) of the arms of the front and rear retainers 31,32 are outwardly turned so as to reduce the risk of the tape 20 catching on the retaining clip 30 during use. The connecting portion 33 comprises three parallel members. The outer two members of the connecting portion 33 connect the front and rear retainers 31,32, and are shaped to conform to the upper surfaces of the cylindrical upper member 12 and the rear wall 13. The central member of the connecting portion 33 has the form of a clip that engages the cylindrical upper member 12 in the assembled configuration of the dose counter mechanism.



FIG. 2 shows the tape housing 10, tape 20, retaining clip 30, and collector spool 40 in an assembled configuration. The roll of tape 20 is held within the dispenser housing 14 by the rear retainer 32 of the retaining clip 30. The tape 20 extends from the dispenser housing 14, along the rear surface of the rear wall 13, over the cylindrical upper member 12, along the front surface of the tape display plate 15, through the slot 17, and into the collector spool housing 16. The retaining clip 30 is engaged with the cylindrical upper member 12 so as to overlie the tape 20 between the dispenser housing 14 and the upper end of the tape display plate 15. The retaining clip 30 acts to maintain the tape 20 in relatively taut state, and also to urge the tape 20 against the front surface of the tape display plate 15, as well as preventing displacement of the roll of tape from the dispenser housing 14.


The collector spool 40 comprises an end plate 42 that is in abutment with the open end of the collector spool housing 16, and a cylindrical shaft (not visible in FIG. 2) housed within the collector spool body 16, the end of which engages in an opening in the side wall 11 of the tape housing 10 such that the collector spool 40 can rotate. The tape 20 enters the collector spool housing 16 through the slot 17, and is guided by the radiussed surface of the collector spool housing 16 that defines the upper edge of the slot 17 to the upper surface of the collector spool 40. The end of the tape 20 is fixed to the collector spool 40 such that rotation of the collector spool 40 in a clockwise direction (as viewed in FIGS. 1 and 2) winds the tape onto the cylindrical body of the connector spool 40.


The end plate 42 has the form of a circular disc, with three pegs 44 provided on the outwardly-facing surface of the end plate 42. The three pegs 44 are spaced equiangularly about a peripheral part of the outwardly-facing surface of the end plate 42, and each peg 44 comprises a cylindrical neck and an enlarged head.


In a fully charged dry powder inhaler, the dose counter mechanism is assembled such that the majority of the tape 20 is held in the dispenser housing 14 in the form of a roll 24. As described above, the tape 20 extends along the front surface of the tape display plate 15, and the end of the tape 20 is fixed to the collector spool 40. In this configuration, the printed number 22 that indicates the number of doses contained within the fully charged dry powder inhaler is located over a viewing part of the tape display plate 15. The dry powder inhaler has a transparent window that overlies the viewing part of the tape display plate 15, such that this printed number 22 is visible.


From this fully charged configuration, the user depresses and then releases the actuator 50 of the dry powder inhaler to dispense a dose of medicament. The actuator 50 is spring-loaded within the dry powder inhaler so that it returns to its inoperative configuration once released by the user.


Each depression and release of the actuator 50 causes the collector spool 40 to be rotated through 120°, thereby causing a pre-determined length of the tape 20 to be wound onto the collector spool 40. This, in turn, causes the tape 20 to be advanced along the tape display plate 15, such that the next printed number 22 in the series is located over a viewing part of the tape display plate 15 and hence visible through the transparent window of the dry powder inhaler.


This action is achieved using an actuator 50 having the form shown in FIG. 3. The actuator 50 comprises a shaft 52 that is operably connected to an actuator button (not shown in the Figures) of the dry powder inhaler, such that the actuator 50 is displaced downwardly (as viewed in FIG. 3) when the actuator button is depressed, and is returned to its inoperative position when the actuator button is released.


The actuator 50 also has a portion that engages the end plate 42 of the collector spool 40 so as to effect rotation of the collector spool 40 on depression and release of the actuator button, as discussed above. This portion comprises downwardly-extending first and second actuator arms 54,56, each with an arcuate engagement member 55,57 at its lower end for engaging a peg 44 of the end plate 42. In particular, the engagement member 55 of the first actuator arm 54 is adapted to engage the upper surface of a peg 44, pushing that peg 44 downwards, and the engagement member 57 of the second actuator arm 56 is hooked, so as to engage the lower surface of a peg 44.


The first and second actuator arms 54,56 are shown in FIGS. 4 and 5 in engagement with the end plate 42 of the collector spool 40. Before depression of the actuator button, and downward displacement of the actuator 50, the actuator arms 54,56 each engage a peg 44 of the end plate 42, as shown in FIG. 4. In particular, the engagement member 57 of the second actuator arm 56 is in engagement with the lower surface of a peg 44 on the left-hand side of the end plate 42 (as viewed in FIG. 4), and the end of the engagement member 55 of the first actuator arm 54 is in contact with the upper surface of a peg 44 on the right-hand side of the end plate 42.


Depression of the actuator button, and hence downward displacement of the actuator 50, causes the engagement member 55 of the first actuator arm 54 to engage the upper surface of the peg 44 with which it is in contact, and urge that peg 44 downwards. This causes the endplate 42, and hence the collector spool 40, to rotate in a clockwise direction. The engagement member 57 of the second actuator arm 56 will be displaced downwardly by this action, rotating the end plate 42 through 120° from the configuration shown in FIG. 4. This condition is shown in FIG. 5.


Release of the actuator button, and hence upward displacement of the actuator 50, will cause the engagement member of the second actuator arm 56 to return to its rest position, at which it engages a peg 44 from below, thereby holding the endplate 42, and hence the collector spool 40, in the position to which it has been rotated. The arrangement is then once again as shown in FIG. 4 (but with the engagement members of the first and second actuator arms 54,56 engaged with different pegs 44).


The remaining parts of the actuator 50 are specific to the dry powder inhaler with which the dose counter mechanism is used, but the actuator 50 will include means for enabling a dose of medicament to be dispensed on depression of the actuator 50.


As described above, each depression and release of the actuator button will cause a dose of medicament to be dispensed, and the collector spool 40 to rotate 120° so that the next number 22 in the series of numbers printed on the tape 20 is visible to the user.

Claims
  • 1. The medicament delivery device comprising a bulk medicament reservoir and a dose counter mechanism, wherein the dose counter mechanism comprises a rollable tape provided with indicia, a tape housing, and a tape collector spool, wherein the tape housing comprises a tape dispenser housing and a tape collector spool housing, wherein the tape collector spool housing is connected to the tape dispenser housing by a tape display area, wherein the tape dispenser housing comprises an enclosure within which a roll of the tape is housed, and an opening through which the tape exits the tape dispenser housing, the tape being formed into the roll that is held in the tape dispenser housing without being wound on a bobbin, wherein the tape collector spool is mounted within the tape collector spool housing, and wherein the tape overlies an outward-facing surface of the tape display area.
  • 2. The medicament delivery device as claimed in claim 1, wherein the rollable tape is formed of a plastics material.
  • 3. The medicament delivery device as claimed in claim 1, wherein the indicia are printed on a surface of the tape.
  • 4. The medicament delivery device as claimed in claim 1, wherein the tape dispenser housing comprises an enclosing wall having a generally C-shaped cross-section, and end flanges that prevent lateral movement of the roll of tape.
  • 5. The medicament delivery device as claimed in claim 1, wherein the outward-facing surface of the tape display area is a smooth and generally flat surface, and at least one of the indicia provided on the part of the tape overlying the tape display area is visible to a user in use.
  • 6. The medicament delivery device as claimed in claim 1, wherein the tape collector spool is rotatably mounted within the tape collector spool housing.
  • 7. The medicament delivery device as claimed in claim 1, wherein the dispenser housing, the collector spool housing, and the tape display area are formed as a single component.
  • 8. The medicament delivery device as claimed in claim 1, further comprising a retaining clip to ensure that the tape is sufficiently taut for the indicia to be readily visible.
  • 9. The medicament delivery device as claimed in claim 1, wherein an actuator of the dose counter mechanism is adapted to rotate the collector spool by a pre-determined degree on being displaced along a linear path and then returned to its inoperative position.
  • 10. The medicament delivery device as claimed in claim 1, wherein the collector spool comprises an end plate having a plurality of projections that are engageable by an actuator, during use, to cause rotation of the collector spool.
  • 11. The medicament delivery device as claimed in claim 10, wherein the projections are spaced equiangularly about a peripheral part of the end plate.
  • 12. The medicament delivery device as claimed in claim 10, wherein the actuator comprises first and second actuator arms, the first actuator arm engaging the collector spool when the actuator is displaced from its inoperative position, and the second actuator arm engaging the collector spool on the return stroke of the actuator to its inoperative position.
  • 13. The medicament delivery device as claimed in claim 12, wherein the first actuator arm is engaged with a projection when the actuator is in its inoperative position, or the first actuator arm engages a projection immediately upon displacement of the actuator from its inoperative position, which then causes the first actuator arm to exert a force on the projection with which it is engaged so as to rotate the collector spool.
  • 14. The medicament delivery device as claimed in claim 1, which is an inhaler.
  • 15. The medicament delivery device as claimed in claim 1, which is a dry powder inhaler.
  • 16. The medicament delivery device as claimed in claim 1, wherein the dose counter mechanism further comprises an actuator that acts to rotate the collector spool by a pre-determined degree each time a dose of medicament is dispensed from the bulk medicament reservoir of the medicament delivery device.
  • 17. The medicament delivery device as claimed in claim 16, wherein the actuator is operably linked to an actuator of the medicament delivery device that enables or causes a dose of medicament to be dispensed.
  • 18. The medicament delivery device as claimed in claim 16, wherein the actuator is operably linked to an actuator of the medicament delivery device that enables or causes a dose of medicament to be dispensed, and the actuator of the dose counter mechanism and the actuator of the medicament delivery device have a common component.
  • 19. The medicament delivery device as claimed in claim 1, wherein the tape dispenser housing comprises an opening through which the tape exits the tape dispenser housing and the tape collector spool housing comprises an opening through which the tape enters the tape collector spool housing, wherein the openings of the tape dispenser housing and the tape collector spool housing face in opposite directions.
  • 20. The medicament delivery device as claimed in claim 1, wherein the enclosure of the tape dispenser housing houses only the roll of tape.
  • 21. A medicament delivery device comprising a bulk medicament reservoir and dose counter mechanism, wherein the dose counter mechanism comprises a rollable tape provided with indicia, a tape housing, and a tape collector spool, wherein the tape housing comprises a tape dispenser housing and a tape collector spool housing, wherein the tape collector spool housing is connected to the tape dispenser housing by a tape display plate, wherein the tape dispenser housing comprises an enclosure within which a roll of the tape is housed, and an opening through which the tape exits the tape dispenser housing, the tape being formed into the roll that is held in the tape dispenser housing without being wound on a bobbin, wherein the tape collector spool is mounted within the tape collector spool housing, and wherein the tape overlies an outward-facing surface of the tape display plate.
Priority Claims (1)
Number Date Country Kind
0409197.1 Apr 2004 GB national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/GB2005/001572 4/22/2005 WO 00 10/19/2006
Publishing Document Publishing Date Country Kind
WO2005/102430 11/3/2005 WO A
US Referenced Citations (147)
Number Name Date Kind
1858735 Goodsell May 1932 A
2587215 Priestly Feb 1952 A
3008609 Sessions Nov 1961 A
3439823 Morane Apr 1969 A
3798054 Kawata et al. Mar 1974 A
3854626 Krechmar Dec 1974 A
3874381 Baum Apr 1975 A
3876269 Fisher et al. Apr 1975 A
4047635 Bennett, Jr. Sep 1977 A
4114615 Wetterlin Sep 1978 A
4174034 Hoo Nov 1979 A
4200099 Guenzel et al. Apr 1980 A
4274403 Struve Jun 1981 A
4524769 Wetterlin Jun 1985 A
4534343 Nowacki et al. Aug 1985 A
4570630 Elliott et al. Feb 1986 A
4604847 Moulding, Jr. et al. Aug 1986 A
4624442 Duffy et al. Nov 1986 A
4627432 Newell et al. Dec 1986 A
4635829 Brittingham, Jr. Jan 1987 A
4668218 Virtanen May 1987 A
4811731 Newell et al. Mar 1989 A
4860740 Kirk et al. Aug 1989 A
4882210 Romberg et al. Nov 1989 A
4895719 Radhakrishnan et al. Jan 1990 A
4907583 Wetterlin et al. Mar 1990 A
4934358 Nilsson et al. Jun 1990 A
4950365 Evans Aug 1990 A
5002048 Makiej, Jr. Mar 1991 A
5007419 Weinstein et al. Apr 1991 A
5042472 Bunin Aug 1991 A
5053237 Hendricks et al. Oct 1991 A
5064083 Alexander et al. Nov 1991 A
5067491 Taylor, II et al. Nov 1991 A
5113855 Newhouse May 1992 A
5152422 Springer Oct 1992 A
5154326 Chang et al. Oct 1992 A
5161524 Evans Nov 1992 A
5169029 Behar et al. Dec 1992 A
5187512 Kirkendall Feb 1993 A
5192528 Radhakrishnan et al. Mar 1993 A
5207217 Cocozza et al. May 1993 A
5208226 Palmer May 1993 A
5253782 Gates et al. Oct 1993 A
5263475 Altermatt et al. Nov 1993 A
5295479 Lankinen Mar 1994 A
5301666 Lerk et al. Apr 1994 A
5347999 Poss et al. Sep 1994 A
5351683 Chiesi et al. Oct 1994 A
5394868 Ambrosio et al. Mar 1995 A
5409132 Kooijmans et al. Apr 1995 A
5411175 Armstrong et al. May 1995 A
5415162 Casper et al. May 1995 A
5435301 Herold et al. Jul 1995 A
5437267 Weinstein et al. Aug 1995 A
5437270 Braithwaite Aug 1995 A
5447151 Bruna et al. Sep 1995 A
5450160 Tianello et al. Sep 1995 A
5458135 Patton et al. Oct 1995 A
5485939 Tucker Jan 1996 A
5503144 Bacon Apr 1996 A
5520166 Ritson et al. May 1996 A
5524613 Haber et al. Jun 1996 A
5551597 Lambelet, Jr. et al. Sep 1996 A
5562231 Lambelet, Jr. et al. Oct 1996 A
5562918 Stimpson Oct 1996 A
5575280 Gupte et al. Nov 1996 A
5617845 Poss et al. Apr 1997 A
5622166 Eisele et al. Apr 1997 A
5653227 Barnes et al. Aug 1997 A
5657748 Braithwaite Aug 1997 A
5657794 Briner et al. Aug 1997 A
5664557 Makiej, Jr. Sep 1997 A
5664697 Lambelet, Jr. et al. Sep 1997 A
5676130 Gupte et al. Oct 1997 A
5678538 Drought Oct 1997 A
D389570 Savolainen Jan 1998 S
5740792 Ashley et al. Apr 1998 A
5740794 Smith et al. Apr 1998 A
5775536 Lambelet, Jr. et al. Jul 1998 A
5778873 Braithwaite Jul 1998 A
5785049 Smith et al. Jul 1998 A
5799821 Lambelet, Jr. et al. Sep 1998 A
5857457 Hyppölä Jan 1999 A
5875776 Vaghefi Mar 1999 A
5881719 Gottenauer et al. Mar 1999 A
5896855 Hobbs et al. Apr 1999 A
5904139 Hauser May 1999 A
5921237 Eisele et al. Jul 1999 A
5924417 Braithwaite Jul 1999 A
5941241 Weinstein et al. Aug 1999 A
5944660 Kimball et al. Aug 1999 A
5955439 Green Sep 1999 A
5981549 Viner Nov 1999 A
5996577 Ohki et al. Dec 1999 A
6006747 Eisele et al. Dec 1999 A
6035463 Pawelzik et al. Mar 2000 A
6065471 Schaeffer et al. May 2000 A
6065472 Anderson et al. May 2000 A
6076521 Lindahl et al. Jun 2000 A
6089227 Nilsson Jul 2000 A
6116238 Jackson et al. Sep 2000 A
6116239 Volgyesi Sep 2000 A
6119688 Whaley et al. Sep 2000 A
6125844 Samiotes Oct 2000 A
6138668 Patton et al. Oct 2000 A
6158675 Ogi Dec 2000 A
6196218 Voges Mar 2001 B1
6220243 Schaeffer et al. Apr 2001 B1
6234167 Cox et al. May 2001 B1
6240918 Ambrosio et al. Jun 2001 B1
6254854 Edwards et al. Jul 2001 B1
6273085 Eisele et al. Aug 2001 B1
6321747 Dmitrovic et al. Nov 2001 B1
6324428 Weinberg et al. Nov 2001 B1
6325241 Garde et al. Dec 2001 B1
6328034 Eisele et al. Dec 2001 B1
6347629 Braithwaite Feb 2002 B1
6418926 Chawla Jul 2002 B1
6435372 Blacker et al. Aug 2002 B1
6443146 Voges Sep 2002 B1
6446627 Bowman et al. Sep 2002 B1
6484718 Schaeffer et al. Nov 2002 B1
6523536 Fugelsang et al. Feb 2003 B2
6543443 Klimowicz et al. Apr 2003 B1
6553987 Davies Apr 2003 B1
6557550 Clarke May 2003 B1
6557552 Cox et al. May 2003 B1
6601729 Papp Aug 2003 B1
6616914 Ward et al. Sep 2003 B2
6675839 Braithwaite Jan 2004 B1
6698425 Widerström Mar 2004 B1
6810873 Haikarainen et al. Nov 2004 B1
6810874 Koskela et al. Nov 2004 B1
6845772 Braithwaite et al. Jan 2005 B2
6926003 Seppälä Aug 2005 B2
20020066451 Davies et al. Jun 2002 A1
20020078949 O'Leary Jun 2002 A1
20030075172 Johnson et al. Apr 2003 A1
20030116157 Braithwaite et al. Jun 2003 A1
20030136406 Seppala Jul 2003 A1
20040011357 Braithwaite Jan 2004 A1
20040094152 Harvey et al. May 2004 A1
20040101482 Sanders May 2004 A1
20040236282 Braithwaite Nov 2004 A1
20040251318 Braithwaite Dec 2004 A1
20050121023 Braithwaite Jun 2005 A1
Foreign Referenced Citations (76)
Number Date Country
14 98 398 Jan 1969 DE
0 045 522 Feb 1982 EP
0 079 478 May 1983 EP
0 166 294 Oct 1989 EP
0 372 777 Jun 1990 EP
0 424 790 May 1991 EP
0 448 204 Sep 1991 EP
0 469 814 Feb 1992 EP
0 514 085 Nov 1992 EP
0 520 440 Dec 1992 EP
0 539 469 BI May 1993 EP
0 573 128 Dec 1993 EP
0 626 689 Nov 1994 EP
0 659 432 Jun 1995 EP
1 062 962 Dec 2000 EP
1 106 196 Jun 2001 EP
1 208 863 May 2002 EP
1616592 Jan 2006 EP
1196146 Sep 2006 EP
3908 Jan 1911 GB
1 242 211 Aug 1971 GB
1 573 551 Aug 1980 GB
2 041 763 Sep 1980 GB
2 165 159 Apr 1986 GB
2 178 965 Feb 1987 GB
2 235 753 Mar 1991 GB
2 248 400 Apr 1992 GB
2 366 208 Mar 2002 GB
2366208 Mar 2002 GB
WO 9007351 Jul 1990 WO
WO 9104011 Apr 1991 WO
WO 9111173 Aug 1991 WO
WO 9114422 Oct 1991 WO
WO 9200771 Jan 1992 WO
WO 9203175 Mar 1992 WO
WO 9204928 Apr 1992 WO
WO 9209322 Jun 1992 WO
WO 9218188 Oct 1992 WO
WO 9300951 Jan 1993 WO
WO 9316748 Sep 1993 WO
WO 9500128 Jan 1995 WO
WO 9515777 Jun 1995 WO
9517917 Jul 1995 WO
9602231 Feb 1996 WO
9608284 Mar 1996 WO
WO 9700399 Jan 1997 WO
9720589 Jun 1997 WO
9740819 Nov 1997 WO
WO 9826828 Jun 1998 WO
9828033 Jul 1998 WO
9831352 Jul 1998 WO
WO 9830262 Jul 1998 WO
WO 9831352 Jul 1998 WO
WO 9912597 Mar 1999 WO
WO 9913930 Mar 1999 WO
WO 9926676 Jun 1999 WO
WO 0012163 Mar 2000 WO
WO 0064519 Nov 2000 WO
WO 0117595 Mar 2001 WO
0128887 Apr 2001 WO
WO 0139823 Jun 2001 WO
WO 0151030 Jul 2001 WO
WO 0160341 Aug 2001 WO
0187391 Nov 2001 WO
WO 0187378 Nov 2001 WO
0197889 Dec 2001 WO
0200280 Jan 2002 WO
0200281 Jan 2002 WO
WO 02056948 Jul 2002 WO
2004017914 Mar 2004 WO
2004017918 Mar 2004 WO
2004017942 Mar 2004 WO
2004026380 Apr 2004 WO
WO 2004091705 Oct 2004 WO
2005060535 Jul 2005 WO
2006008027 Jan 2006 WO
Non-Patent Literature Citations (2)
Entry
Gerrity, T.R., “Pathophysiological and Disease Constraints on Aerosol Delivery,” Chapter 1, Respiratory Drug Delivery I, ed. Byron, P.R., CRC Press, pp. 1-38 (1990).
Notice of Reasons for Rejection, Japan Patent Application No. 2007-508980 (Jun. 14, 2010).
Related Publications (1)
Number Date Country
20070241025 A1 Oct 2007 US